Caitong International Asset Management Co., LTD Phathom Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 113 shares of PHAT stock, worth $1,111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 179
36.87%
Holding current value
$1,111
Previous $1.45 Million
51.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PHAT
# of Institutions
152Shares Held
66.6MCall Options Held
94KPut Options Held
55.5K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$99.5 Million3.99% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$73.5 Million12.73% of portfolio
-
Jennison Associates LLC7.04MShares$69.3 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA3.65MShares$35.9 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$34.4 Million27.15% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $385M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...